A Glimpse Into The Expert Outlook On CVS Health Through 5 Analysts
Portfolio Pulse from Benzinga Insights
In the last three months, 5 analysts have published ratings on CVS Health (NYSE:CVS), with a mix of somewhat bullish and indifferent sentiments. The average 12-month price target has decreased by 7.8% to $65.0. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance.
August 08, 2024 | 2:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Analysts have mixed views on CVS Health, with a decrease in the average 12-month price target by 7.8% to $65.0. Key analysts have adjusted their ratings and price targets, reflecting dynamic market conditions and company performance.
The mixed analyst ratings and the decrease in the average price target suggest a neutral short-term impact on CVS Health's stock price. The adjustments in ratings and targets reflect the analysts' reactions to recent developments and market conditions.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100